Clearbridge Health Limited announced that Mr. Tan Soon Liang (Chen Shunliang) ("Mr. Tan") has not sought re-election at the annual general meeting of the Company held on 28 June 2023 (the "AGM") and has retired as an independent director of the Company ("Independent Director"). Mr. Mah How Soon (Ma Haoshun) ("Mr. Mah"), an Independent Director of the Company, has been appointed as the chairman of the nominating committee of the Company in place of Mr. Tan. Mr. Mah has ceased to be a member of the remuneration committee of the Company.

Changes to the Composition of the Board and Board Committees: Consequent to the aforesaid changes, the new composition of the Board and board committees shall be as follows: Board of Directors: Mr. Chen Johnson: Non-Executive Non-Independent Chairman, Mr. Yee Pinh Jeremy: Executive Director and Chief Executive Officer, Mr. Andrew John Lord Lead Independent Director, Mr. Mark Benedict Ryan Independent Director, Mr. Mah How Soon (Ma Haoshun) Independent Director. Audit Committee: Mr. Mark Benedict Ryan Chairman, Mr. Andrew John Lord: Member, Mr. Mah How Soon (Ma Haoshun) Member. Nominating Committee: Mr. Mah How Soon (Ma Haoshun): Chairman, Mr. Yee Pinh Jeremy: Member, Mr. Andrew John Lord: Member.

Remuneration Committee: Mr. Andrew John Lord: Chairman, Mr. Chen Johnson: Member, Mr. Mark Benedict Ryan: Member.